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The authors argue that the lack of a widely used,
systematic way to report sites of DNA methylation is a
often a barrier to reproducibility and therefore holds
back research.proaches for single nucleotide polymorphism (SNP)The analysis of DNA methylation has become common-
place in research and many thousands of studies that
rely on this technique have been reported. Nevertheless,
comparisons between these studies and the replication
of their findings, which are key to gaining a true under-
standing of the role differential methylation in health
and disease, are routinely hampered by the lack of
consistency in reporting sites of differential methylation.
In the absence of a common and systematic approach to
naming such sites, attempts at reproducing previously
reported findings are often time consuming or even im-
possible. Efforts are hindered by inappropriate (arbitrary)
naming of sites of methylation and/or by a lack of
reporting of the necessary information needed to repli-
cate data faithfully.
At present, it is often necessary to search through pages
of supplementary data in an attempt to identify assay de-
tails; these often take the form of amplification primer se-
quences that are designed for bisulfite-converted DNA,
which shows little resemblance to the unconverted gen-
ome sequence being interrogated. A commonly used ap-
proach for reporting is to refer to a nearby landmark, such
as the transcriptional start site (TSS) of a neighboring
gene (for example, ‘-45 from the TSS’). However, this is of
limited utility for the majority of genomic CpG sites,
which are found in regions located far from such land-
mark sites. The situation is further complicated by the* Correspondence: Richard.saffery@mcri.edu.au
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genes.
In order to facilitate the rapid replication of methyla-
tion data, we propose a universal system for identifying
specific sites of DNA methylation. There are two ways
that this could be done. First, in accordance with ap-
identification, it could be achieved through the sequen-
tial numbering of sites as they are identified. This has
led to the ‘rs’ nomenclature and the many tens of millions
of sequence variants that are currently represented in
databases such as dbSNP (www.ncbi.nlm.nih.gov/SNP/),
each with a unique identifier. Although this is a prac-
tical system, newly deposited variants are now being
identified by a number of up to nine digits (for example,
rs1457689123) that provides no information on genomic
context or type of sequence variant. This information
needs to be sourced independently. A corresponding ap-
proach for CpG sites in the human genome would be an-
ticipated to have more than 28 million identifiers for each
unique CpG site, as well as many more identifiers for
non-CpG sites of methylation. To some extent, this ap-
proach has already been adopted in the form of the
reporting of the defined names of probes that are found
on commonly used array platforms for methylation profil-
ing (for example, cg12345678 of the Illumina Infinium
HumanMethylation bead arrays). However, these probes
represent only a small proportion of potential methylation
sites, are limited to the human genome, and often cover
more than a single site of potential methylation. Thus, a
naming system based on this platform is of limited utility.
An alternative approach would take advantage of the
currently annotated genomic location of specific sites as
part of the naming system. This has the advantage of
providing immediate spatial context to the associated
site, in addition to providing a unique identifier for each
location. The type of methylation site (CpG, CpH; H=A,
C,T) can be included in the identifier, along with
chromosome location. A caveat is that such an identifier
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labeled CpG1:3435353 has a potentially different loca-
tion in the latest human genome build (hg19) to that in
hg18 (the previous build, which is still widely used).
Nevertheless, we favor this approach of identifying methy-
lation sites as it is already widely in use for describing the
location of many other specific genomic features, so there
should be no barrier to adopting such a system for report-
ing sites of DNA methylation. This approach also has
the major advantage that researchers can immediately
identify the genomic location of any reported methyla-
tion findings.
The time has come to adopt a uniform approach to
the identification of specific sites of genomic methyla-
tion in order to facilitate the replication of studies. We
encourage comment and discussion from other re-
searchers in the epigenomics community, including the
editors of journals that routinely publish DNA methyla-
tion data. We also suggest that researchers carrying out
methylation analyses should consider reporting sites of
methylation using this system. As a first step towards
this, we have generated a dedicated CpG bed file with ID
numbers for all sites in the human hg19 genome assembly
for use in the UCSC Genome Browser (http://genome.
ucsc.edu/). This is available from us on request. We antici-
pate the rapid availability of similar resources for other
genome builds, including those of non-human species.
Abbreviation
TSS: Transcriptional start site.
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